Dra (Cromer-related blood group antigen)-incompatible renal transplantation

Vox Sanguinis

Volumn 74, Issue 2, 1998, Pages 106-108

  Nakache, Richard ^a   Levene, Cyril ^b   Sela, Ruth ^b   Kaufman, Suzana ^c   Shapira, Zaki ^d  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c ASSAF HAROFEH MEDICAL CENTER   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO SYSTEM; CASE REPORT; FEMALE; GRAFT FAILURE; HISTOCOMPATIBILITY; HUMAN; KIDNEY TRANSPLANTATION; KIDNEY TUBULE BASEMENT MEMBRANE; PARENCHYMA; PRIORITY JOURNAL;

ADULT; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; FEMALE; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE;

EID: 0031982967     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030914     Document Type: Article

References (22)

1. Alexander GPJ, Squifflet JR De Bruyere M, Latinne D, Reding R, Gianello P, Carlier M, Pirson Y: Present experience in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987;19:4538-4542.
2. Daniels G: Cromer-related antigens: Blood group determinants on decay-accelerating factor. Vox Sang 1989;56:205-211.
3. Schanfield MS, Stevens JO, Bauman D: The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay. Transfusion 1981;21:571-576.
4. Telen MJ, Hall SE, Green AM, Moulds JJ, Ross WF: Identification of human erythrocyte blood group antigens on decay accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 1988;167:93-98.
5. Parsons SF, Spring FA, Mery AH, Uchikawa M, Mallinson G, Anstee DJ, Rawlinson V, Daha M: Evidence that Cromer-related blood group antigens are carried on decay accelerating factor (DAF) suggests that the Inab phenotype is a novel form of DAF deficiency (abstract). 20th Congr Int Soc Blood Transfus. London, UK 1988, p 116.
6. Lublin DM, Thompson ES, Green AN, Levene C, Telen MJ: Dr(a-) polymorphism of decay accelerating factor: Biochemical, functional and molecular characterization and production of allele-specific transfectants. J Clin Invest 1991; 87:1945-1952.
7. a. Transfusion 1984;24:13-15.
8. a and a family with Dr(a-) in 2 generations. Transfusion 1987;27:64-65.
9. Nowicki B, Moulds J, Hull R, Hull S: A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect Immun 1988;56:1057-1060.
10. Sistonen P, Nevanlinna HR, Virtaranta-Knowles K, Tuominen I, Pirkola A, Green CA, Tippett P: WES, a 'new' infrequent blood group antigen in Finns. Vox Sang 1987;52:111-114.
11. a. Transfusion 1988;28:289-290.
12. a: Family study and survival of chromium-labeled incompatible red cells in a Spanish American patient. Transfusion 1983;23:167-169.
13. a. Transfusion 1985;25:84.
14. a (abstract). Transfusion 1987;27:546.
15. Huber H, Fudenberg HH: Receptor sites of human monocytes for IgG1. Int Arch Allergy 1968;34:18-31.
16. Huber H, Polley MJ, Linscott WD, Fundenberg HH, Mueller-Eberhard HJ: Human monocytes: Distinct receptor sites for the third component of complement and for immunoglobulin G. Science 1968;162:1281-1283.
17. Engelfriet CP, Beckers D, van't Veer MB, von dem Borne AEG K, Ouwehand WH: Recent advances in haemolytic anemia. International Congress ISH-ISBT, Budapest (1982). Transfusion 1983;23:235-252.
18. Weiner E, Atwal A, Thompson KM, Melamed B, Gorick B, Hugh-Jones NC: Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages. Immunology 1987;62:401-404.
19. Weiner E, Jollife VM, Scott HCF: Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their abilities to mediate effector functions in monocytes. Immunology 1988;65:159-163.
20. von dem Borne AEG K, Beckers D, Engelfriet CP: Mechanisms of red cell destruction by non-complement-binding IgG antibodies: Essential role in vivo of the Fc-part of IgG. Br J Haematol 1977;36:484-493.
21. Engelfriet CP, Ouwehad WH: ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies; in Contreras M (ed): Blood Transfusion. The Impact of New Technologies. London, Ballière, Tindall, 1990, pp 321-337.
22. Osborne JM, Chacko GW, Brandt JT, Anderson CL: Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele specific oligonucleotide probes. J Immunol Methods 1994;173:207-217.